```html

Extravasation (Leakage of Fluid)

What is Extravasation (leakage of fluid)?

Extravasation refers to the accidental leakage of fluid—often medication or contrast agents—out of a vein or catheter and into the surrounding soft‑tissue compartments. The term is most commonly used in the contexts of intravenous (IV) therapy, chemotherapy infusion, and radiologic contrast administration. When a substance that is meant to stay inside a blood vessel escapes, it can cause swelling, pain, skin discoloration, and in severe cases tissue damage.

While a small amount of fluid may simply cause a temporary “bag of water” feeling, certain agents (e.g., vesicant chemotherapy drugs) are toxic to the tissues and can lead to ulceration, necrosis, or compartment syndrome if not recognized promptly.

Sources: Mayo Clinic, National Cancer Institute, CDC.

Common Causes

Extravasation can result from mechanical problems, patient‑related factors, or the properties of the infused solution. The most frequent situations include:

• Peripheral IV catheter insertion errors – catheter tip placed too close to the vein wall or in a fragile vein.
• High‑pressure infusion pumps – rapid administration of fluids or drugs can force the solution through a puncture.
• Chemotherapy vesicants – agents such as doxorubicin, vincristine, or melphalan that are toxic to surrounding tissue.
• Contrast media for imaging – iodine‑based or gadolinium agents used during CT or MRI scans.
• Peripheral parenteral nutrition (PPN) – hyperosmolar solutions can irritate the vein wall.
• Blood product transfusion – especially when given through a peripheral line.
• Subclavian or central venous catheter malposition – tip may lie against the vessel wall.
• Patient movement – vigorous arm or hand motion can dislodge a catheter.
• Fragile veins in the elderly, neonates, or patients with chronic illness – less resilient vessel walls.
• Improper catheter securement – loosely taped lines allow migration and perforation.

Associated Symptoms

Extravasation often presents with a recognizable pattern of local changes. Common accompanying signs and symptoms include:

• Swelling (edema) at the infusion site, often expanding outward.
• Warmth or a feeling of heat under the skin.
• Redness or bluish‑purple discoloration (ecchymosis).
• Pain, burning, or throbbing sensation that may worsen with movement.
• Tightness or a “tight band” feeling, especially with larger volumes.
• Decreased sensation or numbness if nerve compression occurs.
• Visible fluid collection or “bubbles” under the skin (rare).
• Delayed healing or ulcer formation when vesicant agents are involved.

When to See a Doctor

Most mild extravasations can be managed promptly by nursing staff, but certain signs indicate the need for immediate professional evaluation:

• Severe or worsening pain unrelieved by elevation.
• Rapidly enlarging swelling that spreads beyond the immediate infusion site.
• Skin changes suggestive of tissue injury (blistering, necrosis, or deep ulceration).
• Loss of pulse or decreased capillary refill in the affected limb.
• Fever, chills, or systemic signs that could indicate infection.
• Any extrusion of a vesicant chemotherapy drug.
• Persistent discoloration or swelling lasting >24–48 hours.

If any of these occur, contact your health‑care provider right away or go to the nearest emergency department.

Diagnosis

Evaluation of extravasation combines a focused physical exam with targeted investigations when needed.

Clinical Assessment

1. Visual inspection – size, color, and extent of swelling.
2. Palpation – tenderness, temperature, and tissue consistency.
3. Functional test – ask the patient to move the affected limb; increased pain may indicate compartment pressure.
4. Review of infusion details – type of fluid, volume infused, rate, and catheter gauge.

Imaging (when indicated)

• Ultrasound – delineates fluid collection and differentiates from hematoma.
• Contrast‑enhanced CT or MRI – reserved for large‑volume extravasation or suspicion of deep‑tissue injury.
• Compartment pressure measurement – if compartment syndrome is suspected (pressure >30 mm Hg).

Laboratory Tests

Typically not required unless infection is a concern. In that case, a CBC and wound culture may be ordered.

Treatment Options

Management is driven by the type of fluid, volume extravasated, and severity of tissue involvement.

Immediate First‑Aid Measures (often done by nursing staff)

• Stop the infusion immediately.
• Leave the catheter in place (unless it is obviously displaced) to allow aspiration of residual drug.
• Aspirate any remaining fluid from the catheter using a syringe.
• Elevate the affected limb to reduce swelling.
• Apply a cold or warm compress – cold for non‑vesicant fluids (reduces edema), warm for vesicants (promotes vasodilation and drug dispersion). Follow institutional protocol.

Pharmacologic Interventions

• Antidotes for chemotherapy vesicants – e.g., dexrazoxane for anthracycline extravasation, hyaluronidase for certain agents.
• Topical corticosteroids – may reduce inflammation for non‑vesicant leaks.
• Analgesics – acetaminophen or NSAIDs for pain, avoiding agents that impair platelet function if bleeding risk exists.
• Antibiotics – only if secondary infection is evident.

Advanced Care

• Surgical debridement – required for extensive necrosis or compartment syndrome.
• Negative‑pressure wound therapy (NPWT) – promotes healing of large soft‑tissue defects.
• Physical therapy – restores range of motion after swelling subsides.

Home Care (after discharge)

1. Continue limb elevation for 24–48 hours.
2. Apply gentle warm compresses 3–4 times daily (unless contraindicated).
3. Monitor the area for increasing pain, redness, or discharge.
4. Keep the site clean; use mild soap and dry gently.
5. Follow up with your infusion team or wound‑care nurse as instructed.

Prevention Tips

Many extravasations are avoidable with proper technique and vigilance.

• Choose appropriate veins – use larger, straight veins in the forearm rather than small hand veins.
• Use the smallest gauge catheter that will accommodate the intended therapy.
• Secure catheters firmly with transparent dressings and avoid excessive movement.
• Use infusion pumps with pressure alarms and set limits according to institutional policy.
• Rotate infusion sites for long‑term therapy (e.g., every 72 hours).
• Educate patients to report any burning, tingling, or swelling immediately.
• Implement check‑lists before starting vesicant chemotherapy – verify catheter patency, infusion rate, and antidote availability.
• Consider central venous access for repeated vesicant administration.

Emergency Warning Signs

Key Take‑aways

Extravasation is an iatrogenic complication that can range from a minor inconvenience to a serious tissue‑injuring event. Prompt recognition, appropriate first‑aid measures, and timely medical treatment are essential to limit damage. By following prevention strategies—proper vein selection, secure catheter placement, and patient education—the risk can be dramatically reduced.

For personalized advice, always discuss your IV or chemotherapy plan with your health‑care team. If you experience any concerning signs, seek professional help without delay.

References:

• Mayo Clinic. “Extravasation of chemotherapy.” mayoclinic.org
• National Cancer Institute. “Chemotherapy extravasation.” cancer.gov
• CDC. “Intravenous infusion therapy safety.” cdc.gov
• World Health Organization. “Safe injection practices.” who.int
• Cleveland Clinic. “Compartment syndrome.” clevelandclinic.org

```